company background image
IMM logo

Immutep ASX:IMM Stock Report

Last Price


Market Cap







13 Jun, 2024


Company Financials +

Immutep Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Immutep
Historical stock prices
Current Share PriceAU$0.41
52 Week HighAU$0.48
52 Week LowAU$0.26
1 Month Change-8.89%
3 Month Change12.33%
1 Year Change36.67%
3 Year Change-33.33%
5 Year Change57.69%
Change since IPO-86.33%

Recent News & Updates

Recent updates

Is Immutep (ASX:IMM) Weighed On By Its Debt Load?

May 19
Is Immutep (ASX:IMM) Weighed On By Its Debt Load?

Shareholder Returns

IMMAU BiotechsAU Market

Return vs Industry: IMM exceeded the Australian Biotechs industry which returned -0.5% over the past year.

Return vs Market: IMM exceeded the Australian Market which returned 8.2% over the past year.

Price Volatility

Is IMM's price volatile compared to industry and market?
IMM volatility
IMM Average Weekly Movement9.0%
Biotechs Industry Average Movement11.4%
Market Average Movement8.7%
10% most volatile stocks in AU Market16.5%
10% least volatile stocks in AU Market3.2%

Stable Share Price: IMM has not had significant price volatility in the past 3 months.

Volatility Over Time: IMM's weekly volatility (9%) has been stable over the past year.

About the Company


Immutep Limited, a clinical-stage biotechnology company, engages in developing novel LAG-3 Immunotherapy for cancer and autoimmune diseases. The company is involved in advancing therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system. Its LAG-3 immunotherapies are designed to harness and strengthen the power of patients' immune systems to fight cancer and autoimmune disease.

Immutep Limited Fundamentals Summary

How do Immutep's earnings and revenue compare to its market cap?
IMM fundamental statistics
Market capAU$569.82m
Earnings (TTM)-AU$40.50m
Revenue (TTM)AU$3.93m


P/S Ratio


P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IMM income statement (TTM)
Cost of RevenueAU$37.72m
Gross Profit-AU$33.79m
Other ExpensesAU$6.71m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date


Earnings per share (EPS)-0.028
Gross Margin-859.57%
Net Profit Margin-1,030.32%
Debt/Equity Ratio0.8%

How did IMM perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.